Posted by Michael Wonder on 12 Jun 2017
Drug prices: this time is different
11 June 2017 - Yet another congressional hearing on drug prices is on tap. Investors should resist the temptation to ignore it.
On Tuesday, the U.S. Senate Committee on Health, Education, Labor & Pensions will explore how the American drug-delivery system affects what patients pay for their medications.
This will be one for investors to watch. Taking action on high medical costs is often discussed, and historically has come with minimal action.
